Home > Archive >

Volume 36 (2017)

Number 1

Community Gardening for Patients With Diabetes Mellitus in an Underserved Community: A Pilot Study (pages 4-9)

Pratima R. Nayak, M.D., Jie Hu, Ph.D., R.N., F.A.A.N., Elizabeth A. Snyder, R.D., L.D., C.D.E., Natalie M. Stephens, R.D., Sarah A. Jonaus, M.D., Steven W. Ing, M.D., The Ohio State University Wexner Medical Center, Columbus, OH

The Benefits of Peer Support for Parents of Children With Type 1 Diabetes (pages 10-12)

Elisa Brier Cruz, Licensed Clinical Psychologist, Bronx, NY; M.S. Candidate, Diabetes Education and Management, Teachers College, Columbia University

Journal Watch (pages 13-14)

Kathleen Wyne, M.D., Ph.D.

Fixed Dose Combinations (FDCs): From Orals to Injectables (pages 15-17)

Kathleen Wyne, M.D., Ph.D.

Number 2

What to Tell Your Patients about Insulin Pen Devices (pages 2-4)

Julienne K. Kirk, PharmD, CDE, Professor, Family and Community Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina

The Relationship between Microbiota and the Environment, Nutrition and Metabolic Disease (pages 6-14)

Meghan Jardine, MS, MBA, RDN, LD, CDE, Associate Director of Diabetes Education, Physicians Committee for Responsible Medicine, Washington, D.C.

Educator’s Corner (pages 5)

Meghan Jardine, MS, MBA, RDN, LD, CDE, Associate Director of Diabetes Education, Physicians Committee for Responsible Medicine, Washington, D.C.

Journal Watch (pages 15)

Kathleen Wyne, M.D., Ph.D.

Commentary: What is the Role of Blood Glucose Monitoring in T2DM? (pages 16-17)

Kathleen Wyne, M.D., Ph.D.

Number 3

Should SGLT2 Inhibitors Be Used to Treat Type 1 Diabetes? (pages 2-6)

Kathleen Wyne, MD, PhD, Associate Professor, Division of Endocrinology, Diabetes and Metabolism The Ohio State University, Wexner Medical Center Columbus, Ohio

The Cadillac Combination for Type 2 Diabetes: A GLP-1 receptor Agonist and a SGLT2 Inhibitor (pages 10-13)

David S. H. Bell, MB, FACE, FACP Professor of Medicine (retired) University of Alabama and Southside Endocrinology Birmingham, Alabama, and Edison Goncalves, MD, FACE, FACP Diabetes and Thyroid Associates Birmingham, Alabama

Commentary: Application of the AACE 2017 Lipid Guidelines to Diabetes (pages 7-9)

Kathleen Wyne, M.D., Ph.D.

Engaging the Family in Diabetes Management: Educator’s Corner (pages 14-17)

Annie Chathanatt Mathew, PharmD, CDE, Ambulatory Care Specialist, Parkland Health and Hospital System, Dallas, Texas

Number 4

Assessment of Hypoglycemia (pages 3-6)

Kathleen Wyne, M.D., Ph.D., Associate Professor, Division of Endocrinology, Diabetes and Metabolism, The Ohio State University, Wexner Medical Center Columbus, Ohio, and Laila Al-Hail, M.D., Hamad Medical Hospital Doha, Qatar

Commentary: Long-term Diabetes Management Requires a Road Map (pages 7-8)

Kathleen Wyne, M.D., Ph.D.

Journal Watch (pages 9-12)

Kathleen Wyne, M.D., Ph.D.

Working on the Front End of the Diabetes Continuum: How to Bring the Diabetes Prevention Program to Your Community: Educator’s Corner (pages 13-16)

Kathleen Wyne, M.D., Ph.D.